BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38074447)

  • 1. An extremely rare case of recurrent pleomorphic myxoidliposarcoma with response to eribulin chemotherapy - A case report.
    Rao R; Rastogi S; Kashyap D; Shamim SA; Barwad A
    Rare Tumors; 2023; 15():20363613231212380. PubMed ID: 38074447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib.
    Endo M; Kataoka T; Fujiwara T; Tsukushi S; Takahashi M; Kobayashi E; Yamada Y; Tanaka T; Nezu Y; Hiraga H; Wasa J; Nagano A; Nakano K; Nakayama R; Hamada T; Kawano M; Torigoe T; Sakamoto A; Asanuma K; Morii T; Machida R; Sekino Y; Fukuda H; Oda Y; Ozaki T; Tanaka K
    BMC Cancer; 2023 Mar; 23(1):219. PubMed ID: 36890471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eribulin Provides a Remarkable Effect in Trabectedin-Resistant Myxoid Liposarcoma.
    Tamiya H; Sabe H; Yamashita K; Imura Y; Wakamatsu T; Takenaka S
    Case Rep Orthop; 2020; 2020():8873185. PubMed ID: 33274094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare case of myxoid pleomorphic liposarcoma in an infant: A report.
    Gami S; Tiwari SB; Gautam K; Sharma S; Shrivastav S; Sapkota R
    Int J Surg Case Rep; 2021 Oct; 87():106365. PubMed ID: 34517205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.
    Gronchi A; Ferrari S; Quagliuolo V; Broto JM; Pousa AL; Grignani G; Basso U; Blay JY; Tendero O; Beveridge RD; Ferraresi V; Lugowska I; Merlo DF; Fontana V; Marchesi E; Donati DM; Palassini E; Palmerini E; De Sanctis R; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Casali PG
    Lancet Oncol; 2017 Jun; 18(6):812-822. PubMed ID: 28499583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Established and Experimental Systemic Treatment Options for Advanced Liposarcoma.
    Schöffski P
    Oncol Res Treat; 2022; 45(9):525-543. PubMed ID: 35609512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological Features of Myxoid Pleomorphic Liposarcoma in an African Pygmy Hedgehog (
    Lee EJ; Jeong KS
    Vet Sci; 2022 Nov; 9(11):. PubMed ID: 36423091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myxoid pleomorphic liposarcoma-a clinicopathologic, immunohistochemical, molecular genetic and epigenetic study of 12 cases, suggesting a possible relationship with conventional pleomorphic liposarcoma.
    Creytens D; Folpe AL; Koelsche C; Mentzel T; Ferdinande L; van Gorp JM; Van der Linden M; Raman L; Menten B; Fritchie K; von Deimling A; Van Dorpe J; Flucke U
    Mod Pathol; 2021 Nov; 34(11):2043-2049. PubMed ID: 34168281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myxoid pleomorphic liposarcoma is distinguished from other liposarcomas by widespread loss of heterozygosity and significantly worse overall survival: a genomic and clinicopathologic study.
    Dermawan JK; Hwang S; Wexler L; Tap WD; Singer S; Vanderbilt CM; Antonescu CR
    Mod Pathol; 2022 Nov; 35(11):1644-1655. PubMed ID: 35672466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent Pleomorphic Myxoid Liposarcoma in a Patient With Li-Fraumeni Syndrome.
    Zare SY; Leivo M; Fadare O
    Int J Surg Pathol; 2020 Apr; 28(2):225-228. PubMed ID: 31559875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trabectedin as second-line treatment in metastatic myxoid liposarcoma: a case report.
    Pedrinaci IZ; Jurado JM; Carrillo J; Molina MC
    J Med Case Rep; 2012 Dec; 6():424. PubMed ID: 23253485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term disease control by trabectedin in a patient with dedifferentiated liposarcoma: A case report.
    Matsuda S; Tanaka K; Kawano M; Iwasaki T; Itonaga I; Tsumura H
    Medicine (Baltimore); 2020 Jan; 99(2):e18689. PubMed ID: 31914068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete remission of a reccurrent mesenteric liposarcoma with rare histological features following the administration of trabectedin.
    Tsoukalas N; Tolia M; Lypas G; Panopoulos C; Barbounis V; Koumakis G; Efremidis A
    Oncol Lett; 2014 Jan; 7(1):47-49. PubMed ID: 24348818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy.
    Wang WL; Katz D; Araujo DM; Ravi V; Ludwig JA; Trent JC; Patel SR; Lin PP; Guadagnolo A; Lòpez-Terrada D; Dei Tos AP; Lewis VO; Lev D; Pollock RE; Zagars GK; Benjamin RS; Madewell JE; Lazar AJ
    Clin Sarcoma Res; 2012 Dec; 2(1):25. PubMed ID: 23272660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myxoid Pleomorphic Liposarcoma.
    Dermawan JK
    Surg Pathol Clin; 2024 Mar; 17(1):25-29. PubMed ID: 38278605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myxoid liposarcoma metastatic to the thyroid gland: a case report and literature review.
    Tysome JR; Sandison A; Clarke PM
    J Laryngol Otol; 2006 Jun; 120(6):511-3. PubMed ID: 16563196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing Liposarcomas: Cutting Through the Fat.
    Manji GA; Schwartz GK
    J Oncol Pract; 2016 Mar; 12(3):221-7. PubMed ID: 26962163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myxoid liposarcoma and pleomorphic liposarcoma: cyto-histological correlations].
    Capitanio G; Blandamura S; Barbazza R; Caldart T; Dalla Palma P
    Pathologica; 1989; 81(1075):543-9. PubMed ID: 2641156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal dedifferentiated liposarcoma showing MDM2 amplification: case report.
    Grifasi C; Calogero A; Carlomagno N; Campione S; D'Armiento FP; Renda A
    World J Surg Oncol; 2013 Nov; 11():305. PubMed ID: 24279301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age.
    Alaggio R; Coffin CM; Weiss SW; Bridge JA; Issakov J; Oliveira AM; Folpe AL
    Am J Surg Pathol; 2009 May; 33(5):645-58. PubMed ID: 19194281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.